|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | NPM/ALK downregulates p27^Kip1 in a PI-3K-dependent manner 显示文摘 | Slupianek A Skorski T | 2004 | Exp Hematol2004，32，12： | 1 |
| 2 | Role if phosphatidylinositol 3 kinase-Akt pathway in nucleophosmin/anaplastic lymphoma kinase-mediated lymphomagenesis 显示文摘 | Slupianek A Nieborowska-Skorska M Hoser G | 2001 | Cancer Res2001，61，5： | 1 |
| 3 | BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin 显示文摘 | Slupianek A Gurdek E Koptyra M | 2005 | Oncogene2005，24，24： | 1 |
| 4 | BCR/ABL regulates mammalian RecA homologs,resulting in drug resistance显示文摘 | Slupianek A Schmutte C Tombline G | | Molecules and Cells0，，： | 1 |
| 5 | ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance? 显示文摘 | MAJSTEREK I SLUPIANEK A HOSER G | 2004 | Biochimie2004，86，1： | 1 |
| 6 | Role if phosphatidylinositol 3 kinase - Akt pathway in nucleophos- min/anaplastic lymphoma kinase - mediated lymphomagenesis显示文摘 | Slupianek A Nieborowska - Skorska M Hoser G | 2001 | Cancer Res2001，61，5： | 1 |
| 7 | BCR/ ABL regulates mammalian ReeA homologs,resulting in drug resistance显示文摘 | SLUPIANEK A SCHMUTTE C TOMBLINE G | 2001 | Mol Cell2001，8，4： | 1 |
| 8 | Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis 显示文摘 | Nieborowska-Skorska M Wasik MA Slupianek A | 1999 | J Exp Med1999，189，8： | 1 |
| 9 | Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile显示文摘 | Kimberly Cramer-Morales Margaret Nieborowska-Skorska Kara Scheibner Michelle Padget David A. Irvine Tomasz Sliwinski Kimberly Haas Jaewoong Lee Huimin Geng Darshan Roy Artur Slupianek Feyruz V. Rassool Mariusz A. Wasik Wayne Childers Mhairi Copland Markus | 2013 | Blood2013，，7： | 1 |
| 10 | Enhanced phosphorylation of Nbsl, a member of DNA repair/checkpoint complex Mre11-RAD50-Nbs1, can be targeted to increase the efficacy of imatinib mesylate against BCR/ABL-positive leukemia cells显示文摘 | RINK L SLUPIANEK A STOKLOSA T | 2007 | Blood2007，110，2： | 1 |
| 11 | Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair,prolongation of G(2)/M phase,and protection from apoptosis显示文摘 | Slupianek A Hoser G Majsterek I | 2002 | Mol Cell Biol2002，22，12： | 1 |
| 12 | BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to eisplatin显示文摘 | SLUPIANEK A GURDEK E KOPTYRA M | 2005 | Oncogene2005，24，24： | 1 |
| 13 | Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemognesis显示文摘 | Malgorzata NS Wasik MA Slupianek A | 1999 | J Exp Med1999，189，8： | 1 |
| 14 | BCR/ ABL regulates mammalian RecA homologs, resulting in drug resistance 显示文摘 | SLUPIANEK A SCHMUTTE C TOMBLINE G | 2001 | Mol Cell2001，8，4： | 1 |
| 15 | BCR - ABL1 kinase inhibits uracil DNA glycosylase UNG2 to enhance oxidative DNA damage and stimulate genomic instability 显示文摘 | Slupianek A Falinski R Znojek P | 2013 | Leukemia2013，27，3： | 1 |
| 16 | BCR/ABL modifies the kinetics and fidelity of DNA double-strand breaks repair in hematopoietic cells显示文摘 | Slupianek A Nowicki MO Koptyra M | 2006 | DNA Repair2006，5，： | 1 |
| 17 | BLM helicase is activated in Bcr/Abl leukemia cells to modulate responses to cisplatin 显示文摘 | Slupianek A Gurdek E Koptyra M | 2005 | Oncogene2005，24，24： | 1 |
| 18 | BCR/ABL regulates mammalian RecA homologs,resulting in drug resistance显示文摘 | Slupianek A Schmutte C Tombline G | 2001 | Mol Cell2001，8，4： | 1 |
| 19 | Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair,prolongation of G(2)/M phase,and protection from apoptosis显示文摘 | Slupianek A Hoser G Majsterek I | 2002 | Mol Cell Biol2002，22，12： | 1 |
| 20 | BLM helicase is activated in BCR/ABL leukemia cells to modulate responses to cisplatin显示文摘 | Slupianek A Gurdek E Koptyra M | 2005 | Oncogene2005，24，24： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员